ChipCare | Point of Care | Toronto, ChipCare is addressing sexually transmitted infection (STI) markets and is currently developing the PAx2 platform with multiplexed Chlamydia / Gonorrhea / Trichomoniasis (CT/NG/TV) nucleic acid test and an HIV/Syphilis immunoassay.